Lexaria Bioscience

Youtube Subscribe

Open: 1.11 Close: 1.18 Change: 0.07

How to get information about Lexaria Bioscience Company Inc Stock without reading the whole internet.

The game is changing. There is a new strategy to evaluate Lexaria Bioscience fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Lexaria Bioscience are: Lexaria, Bioscience, Corp, LEXX, SulfoSyn, Cannabis, Expo, …

Concept Map

Semantic Network

Stock Summary

Lexaria Bioscience Corp. develops and out-licenses its DehydraTECH technology. Company's DehydaTECH combines lipophilic molecules with specific long-chain fatty acids. Technology evaluates for a variety of.

Today's Summary

Lexaria Bioscience Corp. raised $1.6 million in latest investment round. The consensus target price of $4.00 suggests a potential upside of 365.12%. Lexaria has entered into securities purchase agreement with SulfoSyn.

Today's News

Lexaria Bioscience Corp. raised $1.6 million in latest investment round; looks to advance dehydratech(TM) research operations. Lexaria has entered into securities purchase agreement with SulfoSyn. The Green Label 4th Annual Cannabis Expo: Drinks, Cannabis and Sustainability Expo: San Francisco. Lexaria Bioscience Corp. (NASDAQ: LEXX) Raised $1.6 million in Latest Investment Round; Looks to Advance DehydraTECH(TM) Research Operations Lexaria. (LEXX) Expands Ongoing Diabetes Study Program to Examine its Patented DehydaTECH. Technology with Launch of Human and Animal Studies for Oral GLP-1 drugs. Lexaria. Biosico company saw Charm drip endemicnan throughQueue Lexaria Bioscience Corp. (NASDAQ: LEXX) Raised $1.6 million in Latest Investment; To Advance DehydraTECH(TM) Operations. Lexaria Enters New Global Exclusive Collaboration and License Agreement with SulfoSyn Global exclusivity for all non-pharmaceutical applications of DehydRATECH-sulforaphane has been awarded. Lexaria Bioscience has higher revenue and earnings than TMC the metals. The consensus target price of $4.00 suggests a potential upside of 365.12%. The company is currently undervalued.

Stock Profile

"Lexaria Bioscience Corp. operates as a biotechnology company. The company develops and out-licenses its DehydraTECH combines lipophilic molecules or active pharmaceutical ingredients with specific long-chain fatty acids and carrier compounds that improve the way they enter the bloodstream, increasing their effectiveness and allowing for lower overall dosing while promoting healthier oral ingestion methods. Its DehydraTECH is used with a range of active molecules encompassing fat-soluble vitamins, pain medications, hormones, PDE5 inhibitors, antivirals, oral nicotine and its analogs, and various cannabinoids. The company's DehydraTECH technology evaluates for a variety of therapeutic indications, including hypertension, heart disease, dementia, and diabetes. It is suitable for a variety of product formats, such as pharmaceuticals, nutraceuticals, over the counter, and consumer packaged goods. Lexaria Bioscience Corp. was incorporated in 2004 and is based in Kelowna, Canada."

Keywords

Are looking for the most relevant information about Lexaria Bioscience? Investor spend a lot of time searching for information to make investment decisions in Lexaria Bioscience. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Lexaria Bioscience are: Lexaria, Bioscience, Corp, LEXX, SulfoSyn, Cannabis, Expo, and the most common words in the summary are: state, united, lexaria, bioscience, nasdaq, inc, follow, . One of the sentences in the summary was: raised $1.6 million in latest investment round. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #state #united #lexaria #bioscience #nasdaq #inc #follow.

Read more →

Youtube Subscribe

---